Table 2:
Characteristics of active RVCL-S lesions at baseline
| All Lesions (N = 44) No. (%) | |
|---|---|
| Size in mm, median (IQR) | 4 (2–8) |
| Location | |
| Periventricular | 12 (27) |
| Deep/subcortical white matter | 17 (39) |
| Basal ganglia/thalamus | 15 (34) |
| Characteristics of activity | |
| Enhancement | |
| Unknowna | 2 (4) |
| No enhancement | 2 (4) |
| Punctiform enhancement | 24 (55) |
| Linear enhancement | 6 (14) |
| Rim enhancement | 10 (23) |
| Diffusion restriction | 22 (50) |
| Other characteristics | |
| T2-hyperintensity | 33 (75) |
| Susceptibility artifacts | 30 (68) |
| Mass effect | 0 |
a
In 1 MC, no contrast was administered due to reduced kidney function. Lesions in this MC showed diffusion restriction.